{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T16:13:37Z","timestamp":1753892017390,"version":"3.41.2"},"reference-count":138,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,4,24]],"date-time":"2025-04-24T00:00:00Z","timestamp":1745452800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"abstract":"<jats:sec><jats:title>Introduction<\/jats:title><jats:p><jats:italic>Sophorae flavescentis<\/jats:italic> (<jats:italic>kushen<\/jats:italic>) preparations are widely used to control malignant pleural effusion (MPE) through intrapleural perfusion.<\/jats:p><\/jats:sec><jats:sec><jats:title>Objectives<\/jats:title><jats:p>This analysis aims to verify the therapeutic values of perfusion with <jats:italic>kushen<\/jats:italic> preparations for controlling MPE, reveal the optimal treatment plan, suitable population, and usage, and to demonstrate their clinical effectiveness and safety.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>We performed and reported this systematic review\/meta-analysis (PROSPERO: CRD42023430139) following the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines. All randomized controlled trials (RCTs) concerning perfusion with <jats:italic>kushen<\/jats:italic> preparation for MPE were collected from Chinese and English databases. We clustered all eligible studies into multiple homogeneous treatment units, assessed their methodological quality using a RoB 2, pooled the data from each unit, and summarized the quality of the evidence.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>We included 83 RCTs reporting three types of <jats:italic>kushen<\/jats:italic> preparation: compound <jats:italic>kushen<\/jats:italic> injection (CKI), <jats:italic>kang\u2019ai<\/jats:italic> injection, and matrine injection. All trials were clustered into perfusion with CKI alone or with the addition of sclerosants, <jats:italic>kang\u2019ai<\/jats:italic>, or matrine-plus platinum for controlling MPE. Compared with cisplatin alone, perfusion with CKI alone displayed a similar complete response, pleurodesis failure, and pleural progression (odds ratios =1.10, 95% CI 0.76 to 1.60; 0.80, 0.56 to 1.14; 0.63, 0.33 to 1.21). Of 14 homogeneous treatment plans, perfusion with CKI and cisplatin significantly improved the complete response (2.71, 2.30 to 3.19) and showed low pleurodesis failure (0.26, 0.22 to 0.32), pleural progression (0.22, 0.14 to 0.36), myelosuppression (0.34, 0.24 to 0.47), neutropenia (0.35, 0.26 to 0.46), gastrointestinal reaction (0.36, 0.29 to 0.44), hepatorenal toxicity (0.42, 0.28 to 0.63 and 0.32, 0.24 to 0.44), and fever (0.50, 0.30 to 0.82). These results were moderate quality (\u2295\u2295\u2295\u039f) supported by firm or conclusive information. Additionally, perfusion with <jats:italic>kang\u2019ai<\/jats:italic> or matrine and cisplatin also improved the complete response (3.04, 1.76 to 5.26 and 1.87, 1.26 to 2.78) and displayed low pleurodesis failure (0.23, 0.14 to 0.41 and 0.27, 0.17 to 0.44). The results were moderate to low quality (\u2295\u2295\u2295\u039f to \u2295\u2295\u039f\u039f).<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>Current moderate evidence demonstrates that CKI may be an effective palliative intervention for MPE which, combined with cisplatin, may be an optimal treatment plan. <jats:italic>Kang\u2019ai<\/jats:italic> or matrine may be other potential choices.<\/jats:p><\/jats:sec><jats:sec><jats:title>Systematic Review Registration:<\/jats:title><jats:p><jats:ext-link>https:\/\/www.crd.york.ac.uk\/PROSPERO\/view\/CRD42023430139<\/jats:ext-link><\/jats:p><\/jats:sec>","DOI":"10.3389\/fphar.2025.1519794","type":"journal-article","created":{"date-parts":[[2025,4,24]],"date-time":"2025-04-24T05:25:41Z","timestamp":1745472341000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Intrapleural administration with traditional Chinese medicine injections (Sophorae flavescentis preparations) in controlling malignant pleural effusion: a clustered systematic review and meta-analysis"],"prefix":"10.3389","volume":"16","author":[{"given":"Yan","family":"Zhang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zheng","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hui","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Da-Chun","family":"Cai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yao-Qin","family":"Luo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiao","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Feng","family":"Luo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yan-Yan","family":"Jin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Teng-Yang","family":"Fan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xue","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ji-Hong","family":"Feng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2025,4,24]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1186\/s12957-015-0729-9","article-title":"Thoracic perfusion of matrine as an adjuvant treatment improves the control of the malignant pleural effusions","volume":"13","author":"Biaoxue","year":"2015","journal-title":"World J. Surg. Oncol."},{"key":"B2","doi-asserted-by":"publisher","first-page":"1800349","DOI":"10.1183\/13993003.00349-2018","article-title":"ERS\/EACTS statement on the management of malignant pleural effusions","volume":"52","author":"Bibby","year":"2018","journal-title":"Eur. Respir. J."},{"key":"B3","first-page":"161","article-title":"Effect of Compound Kushen Injection on elderly patients with lung cancer complicated with malignant pleural effusion","volume":"17","author":"Cai","year":"2019","journal-title":"Contemp. Med. Symp."},{"key":"B4","doi-asserted-by":"publisher","first-page":"1457","DOI":"10.2147\/CMAR.S243127","article-title":"Anti-tumor activities of bioactive phytochemicals in Sophora flavescens for breast cancer","volume":"12","author":"Cao","year":"2020","journal-title":"Cancer Manag. Res."},{"key":"B5","doi-asserted-by":"publisher","first-page":"755","DOI":"10.14188\/j.1671-8852.2013.05.039","article-title":"Meta analysis of Lifein combined with Cisplatin in chest catheterization perfusion chemotheapy for malignant pleural effusion","volume":"34","author":"Chen","year":"2013","journal-title":"Med J Wuhan Univ"},{"key":"B6","doi-asserted-by":"publisher","first-page":"49","DOI":"10.3969\/j.issn.1672-5085.2012.42.039","article-title":"Clinical observation of compound Kushen injection combined with cisplatin on malignant pleural effusion","volume":"9","author":"Chen","year":"2012","journal-title":"World Health Dig."},{"key":"B7","doi-asserted-by":"publisher","first-page":"114914","DOI":"10.1016\/j.jep.2021.114914","article-title":"Research progress of matrine's anticancer activity and its molecular mechanism","volume":"286","author":"Chen","year":"2022","journal-title":"J. Ethnopharmacol."},{"key":"B8","first-page":"2069","article-title":"Effect of compound matrine injection on malignant pleural effusion","volume":"22","author":"Chen","year":"2013","journal-title":"Chin. J. New Drugs"},{"key":"B9","doi-asserted-by":"publisher","first-page":"457","DOI":"10.3969\/j.issn.1673-6575.2003.04.011","article-title":"Treatment of carcinomatous hydrothorax with small tube for closing drainage and infusing Bieomycini Hydrochkuridum and Yanshu","volume":"22","author":"Chen","year":"2003","journal-title":"J. Minim. Invasive Med."},{"key":"B10","doi-asserted-by":"publisher","first-page":"105778","DOI":"10.1016\/j.phrs.2021.105778","article-title":"Biological effects and mechanisms of matrine and other constituents of Sophora flavescens in colorectal cancer","volume":"171","author":"Chen","year":"2021","journal-title":"Pharmacol. Res."},{"key":"B11","doi-asserted-by":"publisher","first-page":"41","DOI":"10.3969\/j.issn.0411-9584.2010.01.019","article-title":"Yanshu injection in the treatment of malignant pleural effusion -28 cases study","volume":"41","author":"Chen","year":"2010","journal-title":"J. Jiangxi TCM"},{"key":"B12","first-page":"27","article-title":"Kangai injection combined with carboplatin in the treatment of malignant pleural effusion","volume":"38","author":"Chen","year":"2009","journal-title":"Heilongjiang J. TCM"},{"key":"B13","doi-asserted-by":"publisher","first-page":"366","DOI":"10.14009\/j.issn.1672-2124.2011.04.016","article-title":"Compound Kushen Injection combined with cisplatin for malignant pleural effusion:A clinical study","volume":"11","author":"Chen","year":"2011","journal-title":"Eval. Anal. Drug-Use Hosp. China"},{"key":"B14","doi-asserted-by":"publisher","first-page":"196","DOI":"10.3969\/j.issn.1674-4616.2014.04.011","article-title":"Effect of compound Kushen injection combined with cisplatin on malignant pleural effusion in aged patients","volume":"6","author":"Chen","year":"2014","journal-title":"Res. Integr. Tradit. Chin. West Med."},{"key":"B15","doi-asserted-by":"publisher","first-page":"65","DOI":"10.3969\/j.issn.1007-3507.2008.02.001","article-title":"Clinical study on the treatment of malignant pleural effusion by pleural catheter drainage and infusion of oxymatrine and carboplatin","volume":"32","author":"Cui","year":"2008","journal-title":"J. Baotou Med."},{"key":"B16","doi-asserted-by":"publisher","first-page":"270","DOI":"10.3969\/j.issn.1672-2779.2008.03.048","article-title":"Observation on efficacy of Yanshu injection combined cisplatin in treating malignant hydrothorax of 40 cases","volume":"6","author":"Deng","year":"2008","journal-title":"Chin. Med. Mod. Dist. Edu China"},{"key":"B17","doi-asserted-by":"publisher","first-page":"1274","DOI":"10.3969\/j.issn.1672-4992.2009.07.026","article-title":"The clinical observation of compound Kushen injection combined with cisplatin in the treatment of malignant pleural effusion by intrathoracic injection","volume":"17","author":"Ding","year":"2009","journal-title":"J. Mod. Oncol."},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.cd010529.pub3","article-title":"Interventions for the management of malignant pleural effusions: a network meta-analysis","volume":"2020","author":"Dipper","year":"2020","journal-title":"Cochrane Database Syst. Rev."},{"key":"B19","first-page":"472","article-title":"Comparison of pleural injection of oxymatrine combined with cisplatin in the treatment of malignant pleural effusion","volume":"3","author":"Du","year":"2009","journal-title":"J. Dis. Monit. Control"},{"key":"B20","doi-asserted-by":"publisher","first-page":"2712","DOI":"10.19540\/j.cnki.cjcmm.20211129.701","article-title":"Anti-tumor and analgesic activity evaluation and mechanism of Compound Kushen Injection","volume":"47","author":"Fan","year":"2022","journal-title":"Zhongguo Zhong Yao Za Zhi"},{"key":"B21","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1164\/rccm.201807-1415ST","article-title":"Management of malignant pleural effusions. An official ATS\/STS\/STR clinical practice guideline","volume":"198","author":"Feller-Kopman","year":"2018","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"B22","doi-asserted-by":"publisher","first-page":"1717","DOI":"10.7501\/j.issn.1674-5515.2023.07.028","article-title":"Clinical study of Compound Kushen Injection combined with cisplatin in treatment of non-small cell lung cancer malignant pleural effusion","volume":"38","author":"Feng","year":"2023","journal-title":"Drugs and Clin."},{"key":"B23","doi-asserted-by":"publisher","first-page":"1188","DOI":"10.1016\/j.amjmed.2022.04.017","article-title":"Malignant pleural effusion: presentation, diagnosis, and management","volume":"135","author":"Gayen","year":"2022","journal-title":"Am. J. Med."},{"key":"B24","doi-asserted-by":"publisher","first-page":"79","DOI":"10.3969\/j.issn.1673-7210.2013.25.029","article-title":"Observation on efficacy of compound Kushen injection combined with cisplatin in the treatment of malignant pleural fluid","volume":"10","author":"Guo","year":"2013","journal-title":"China Med. Her."},{"key":"B25","doi-asserted-by":"publisher","first-page":"840742","DOI":"10.1155\/2015\/840742","article-title":"Efficacy of compound kushen injection in relieving cancer-related pain: a systematic review and meta-analysis","volume":"2015","author":"Guo","year":"2015","journal-title":"Evid. Based Complement. Altern. Med."},{"key":"B26","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1136\/bmj.39489.470347.AD","article-title":"GRADE: an emerging consensus on rating quality of evidence and strength of recommendations","volume":"336","author":"Guyatt","year":"2008","journal-title":"Bmj"},{"key":"B27","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/1471-2288-12-9","article-title":"Enhanced secondary analysis of survival data: reconstructing the data from published Kaplan-Meier survival curves","volume":"12","author":"Guyot","year":"2012","journal-title":"BMC Med. Res. Methodol."},{"key":"B28","doi-asserted-by":"publisher","first-page":"1191","DOI":"10.3969\/j.issn.1671-7171.2013.06.055","article-title":"Effect of compound Kushen injection combined with cisplatin pleural perfusion on malignant pleural effusion","volume":"30","author":"Han","year":"2013","journal-title":"J. Clin. Res."},{"key":"B29","doi-asserted-by":"publisher","first-page":"524","DOI":"10.3969\/j.issn.1005-4561.2012.07.011","article-title":"Effect of closed drainage combined with compound Kushen injection and cisplatin on malignant pleural effusion of lung cancer","volume":"22","author":"Han","year":"2012","journal-title":"Zhejiang J. ITCWM"},{"key":"B30","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.3969\/j.issn.1672-1349.2007.11.051","article-title":"Continuous catheter drainage combined with Yanshu injection and interleukin-2 intrapleural injection in the treatment of malignant pleural effusion","volume":"5","author":"Hao","year":"2007","journal-title":"Chin. J. IMCCD"},{"key":"B31","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1515\/pp-2020-0147","article-title":"Survival and pleurodesis outcome in patients with malignant pleural effusion - a systematic review","volume":"6","author":"Hassan","year":"2021","journal-title":"Pleura Perit."},{"key":"B32","doi-asserted-by":"publisher","first-page":"3756","DOI":"10.3969\/j.issn.1006-1959.2011.08.280","article-title":"Clinical study of Kangai injection combined with cisplatin in treatment of malignant pleural effusion","volume":"24","author":"He","year":"2011","journal-title":"Med. Inf."},{"key":"B33","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.14009\/j.issn.1672-2124.2010.11.012","article-title":"Compound Kushen Injection as a local therapy for patients with advanced lung cancer associated with malignant pleural effusion","volume":"10","author":"He","year":"2010","journal-title":"Eval. Anal. Drug-Use Hosp. China"},{"key":"B34","doi-asserted-by":"publisher","first-page":"261","DOI":"10.3969\/j.issn.1673-1557.2009.04.009","article-title":"Effect of hydroxycamptothecin and Yanshu injection by intrapleural infusion in treatment of 30 cases malignant pleural effusion","volume":"35","author":"He","year":"2009","journal-title":"J. Mod. Clin. Med."},{"key":"B35","doi-asserted-by":"publisher","first-page":"27","DOI":"10.3969\/j.issn.1002-266X.2010.33.017","article-title":"Effect of compound Kushen injection combined with carboplatin on malignant pleural effusion","volume":"50","author":"He","year":"2010","journal-title":"J. Shandong Med."},{"key":"B36","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.jep.2015.06.010","article-title":"Sophora flavescens Ait.: traditional usage, phytochemistry and pharmacology of an important traditional Chinese medicine","volume":"172","author":"He","year":"2015","journal-title":"J. Ethnopharmacol."},{"key":"B37","doi-asserted-by":"publisher","first-page":"415","DOI":"10.3969\/j.issn.1672-1721.2010.13.018","article-title":"Clinical observation of cisplatin combined with oxymatrine in the treatment of malignant pleural effusion","volume":"14","author":"He","year":"2010","journal-title":"Med. Forum"},{"key":"B38","article-title":"Cochrane handbook for systematic reviews of interventions version 6.2 (updated february 2021)","author":"Higgins","year":"2021","journal-title":"Cochrane"},{"key":"B39","doi-asserted-by":"publisher","first-page":"561","DOI":"10.3760\/cma.j.issn.1671-7368.2008.08.027","article-title":"Intrathoracic administration of Kushenhuangqi injection combined with cisplatin in treatment of malignant pleural efusion","volume":"7","author":"Hu","year":"","journal-title":"Chin. J. Gen. Pract."},{"key":"B40","doi-asserted-by":"publisher","first-page":"15","DOI":"10.3969\/j.issn.1004-0668.2008.01.006","article-title":"Effect of Yanshu injection on malignant pleural effusion of advanced lung cancer","volume":"31","author":"Hu","year":"","journal-title":"J. Chengdu Univ. TCM"},{"key":"B41","doi-asserted-by":"publisher","first-page":"29","DOI":"10.14164\/j.cnki.cn11-5581\/r.2017.07.012","article-title":"Analysis of curative effect by compound Kushen injection combined with cisplatin through intrapleural infusion in the treatment of malignant pleural effusion","volume":"11","author":"Huang","year":"2017","journal-title":"Chin. J. Mod. Drug Appl."},{"key":"B42","first-page":"71","article-title":"Clinical effect of compound sophora flavescens injection in palliative treatment of advanced lung cancer patients with malignant pleural effusion","author":"Huang","year":"2021","journal-title":"Health Manag."},{"key":"B43","first-page":"1106","article-title":"Clinical observation on treating pleural effusion of lung cancer with Yan-shu inject plus cisplatin","volume":"20","author":"Huang","year":"2007","journal-title":"J. Pract. Chin. Mod. Med."},{"key":"B44","doi-asserted-by":"publisher","first-page":"692","DOI":"10.3969\/j.issn.1008-2409.2013.04.010","article-title":"Clinical study on intrapleural compound matrine injection in treating malignant hepatocellular carcinoma with bloody pleural effusion","volume":"26","author":"Huang","year":"2013","journal-title":"Acta Med. Sin."},{"key":"B45","doi-asserted-by":"publisher","first-page":"497","DOI":"10.3969\/j.issn.1009-6663.2012.03.056","article-title":"The clinical research of compound Kushen injection and corynebacterium parvum as a local therapy for patients with advanced lung cancer associated with malignant pleural effusion","volume":"17","author":"Huang","year":"2012","journal-title":"J. Clin. Pulm. Med."},{"key":"B46","doi-asserted-by":"publisher","first-page":"92","DOI":"10.3969\/j.issn.1002-266X.2012.29.039","article-title":"Clinical observation of 82 cases of malignant pleural effusion treated with cisplatin combined with matrine","volume":"52","author":"Ji","year":"2012","journal-title":"J. Shandong Med."},{"key":"B47","doi-asserted-by":"publisher","first-page":"155","DOI":"10.3969\/j.issn.1673-7555.2011.29.121","article-title":"Clinical study of 30 cases of malignant pleural effusion treated by cisplatin combined with oxymatrine","volume":"6","author":"Ji","year":"2011","journal-title":"China Prac. Med."},{"key":"B48","doi-asserted-by":"publisher","first-page":"816973","DOI":"10.3389\/fmed.2022.816973","article-title":"Intrapleural perfusion with staphylococcal enterotoxin C for malignant pleural effusion: a clustered systematic review and meta-analysis","volume":"9","author":"Jiang","year":"2022","journal-title":"Front. Med. (Lausanne)"},{"key":"B49","first-page":"113","article-title":"Clinical effect of compound Kushen Injection combined with cisplatin in treatment of malignant pleural effusion","volume":"21","author":"Jiang","year":"2014","journal-title":"China Mod. Med."},{"key":"B50","first-page":"1","article-title":"Compound Sophora flavescens injection and cisplatin in the treatment of malignant pleural effusion: a clinical study","volume":"11","author":"Jiang","year":"2020","journal-title":"Med. and Health"},{"key":"B51","first-page":"92","article-title":"Randomized controlled trial of endostar combined with cisplatin\/pemetrexed chemotherapy for elderly patients with advanced malignant pleural effusion of lung adenocarcinoma","volume":"23","author":"Jie Wang","year":"2018","journal-title":"J. buon"},{"key":"B52","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1177\/1753465815570307","article-title":"Efficacy and safety profile of autologous blood versus tetracycline pleurodesis for malignant pleural effusion","volume":"9","author":"Keeratichananont","year":"2015","journal-title":"Ther. Adv. Respir. Dis."},{"key":"B53","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1002\/jso.2930360202","article-title":"Intracavitary bleomycin and tetracycline in the management of malignant pleural effusions: a randomized study","volume":"36","author":"Kessinger","year":"1987","journal-title":"J. Surg. Oncol."},{"key":"B54","doi-asserted-by":"publisher","first-page":"1052","DOI":"10.13286\/j.cnki.chinhosppharmacyj.2019.10.13","article-title":"Network meta-analysis of 8 traditional Chinese medicine injections combined with cisplatin for malignant pleural effusion","volume":"39","author":"Li","year":"","journal-title":"Chin. Hosp. Pharm. J."},{"key":"B55","doi-asserted-by":"publisher","first-page":"5283","DOI":"10.7150\/jca.31928","article-title":"Kangai injection combined with platinum-based chemotherapy for the treatment of stage III\/IV non-small cell lung cancer: a meta-analysis and systematic review of 35 randomized controlled trials","volume":"10","author":"Li","year":"","journal-title":"J. Cancer"},{"key":"B56","doi-asserted-by":"publisher","first-page":"1289","DOI":"10.16368\/j.issn.1674-8999.2011.11.062","article-title":"Clinical study of cisplatin compound Kushen injection in treating malignant pleural efusion","volume":"26","author":"Li","year":"2011","journal-title":"China J. Chi Med."},{"key":"B57","doi-asserted-by":"publisher","first-page":"39","DOI":"10.3969\/j.issn.1673-7555.2009.36.023","article-title":"Clinical study of oxymatrine injection combined with cisplatin injection in the treatment of malignant pleural effusion","volume":"4","author":"Li","year":"2009","journal-title":"China Prac. Med."},{"key":"B58","doi-asserted-by":"publisher","first-page":"789","DOI":"10.13192\/j.issn.1000-1719.2017.04.041","article-title":"Eficacy of compound Kushen Injection combined with nedaplatin for malignant pleurai efusion","volume":"44","author":"Li","year":"2017","journal-title":"Liaoning J. TCM"},{"key":"B59","doi-asserted-by":"publisher","first-page":"88","DOI":"10.3969\/j.issn.1674-4616.2014.02.010","article-title":"Clinical observation of compound Kushen injection combined with nedaplatin in the treatment of malignant pleural effusion","volume":"6","author":"Li","year":"2014","journal-title":"Res. Integr. Tradit. Chin. West Med."},{"key":"B60","doi-asserted-by":"publisher","first-page":"1978","DOI":"10.3969\/j.issn.1003-8507.2008.10.078","article-title":"The clinical value of cisplatin combined with compound Kushen Injection in treatment of cancerours hydrothorax","volume":"35","author":"Li","year":"2008","journal-title":"Mod. Prev. Med."},{"key":"B61","doi-asserted-by":"publisher","first-page":"42","DOI":"10.3969\/j.issn.1007-5798.2009.04.043","article-title":"Compound Kushen injection combined with cisplatin pleural injection for lung cancer pleural effusion","volume":"17","author":"Li","year":"2009","journal-title":"China Naturop."},{"key":"B62","article-title":"Network meta-analysis and network pharmacology study of Chinese medicine injection combined with cisplatin in the treatment of malignant pleural effusion of lung cancer","volume-title":"Master master","author":"Li","year":"2022"},{"key":"B63","doi-asserted-by":"publisher","first-page":"Cd013106","DOI":"10.1002\/14651858.CD013106.pub2","article-title":"Radix Sophorae flavescentis versus other drugs or herbs for chronic hepatitis B","volume":"6","author":"Liang","year":"2019","journal-title":"Cochrane Database Syst. Rev."},{"key":"B64","doi-asserted-by":"publisher","first-page":"547","DOI":"10.14009\/j.issn.1672-2124.2011.06.014","article-title":"Efficacy of compound matrine injection for malignant pleural effusion","volume":"11","author":"Liang","year":"2011","journal-title":"Eval. Anal. Drug-Use Hosp. China"},{"key":"B65","doi-asserted-by":"publisher","first-page":"465","DOI":"10.3969\/j.issn.1672-2124.2007.06.024","article-title":"Thoracic perfusion of compound Kushen injection plus cisplatin for malignant pleural fluid","volume":"7","author":"Lin","year":"2007","journal-title":"Eval. Anal. Drug-Use Hosp. China"},{"key":"B66","doi-asserted-by":"publisher","first-page":"3758","DOI":"10.13241\/j.cnki.pmb.2023.19.032","article-title":"Effect of intracavitary perfusion of compound Sophora Flavescens injection on the immune function and tumor markers in patients with malignant pleural effusion","volume":"23","author":"Lin","year":"2023","journal-title":"Prog. Mod. Biomed."},{"key":"B67","doi-asserted-by":"publisher","first-page":"21","DOI":"10.7619\/jcmp.201508007","article-title":"Curative effect and nursing of thoracic cavity drainage and compound Kushen injection combined with cisplatin in the treatment of lung cancer patients companying with malignant pleural effusion","volume":"19","author":"Liu","year":"2015","journal-title":"J. Clin. Med. Pract."},{"key":"B68","doi-asserted-by":"publisher","first-page":"821","DOI":"10.6004\/jnccn.2023.7036","article-title":"Compound kushen injection reduces severe toxicity and symptom burden associated with curative radiotherapy in patients with lung cancer","volume":"21","author":"Liu","year":"2023","journal-title":"J. Natl. Compr. Canc Netw."},{"key":"B69","doi-asserted-by":"publisher","first-page":"230","DOI":"10.3969\/j.issn.1672-4992.2017.02.018","article-title":"Effects and safety of compound Kushen injection combined with cisplatin on malignant pleural effusion","volume":"25","author":"Liu","year":"2017","journal-title":"J. Mod. Oncol."},{"key":"B70","doi-asserted-by":"publisher","first-page":"1004259","DOI":"10.3389\/fphar.2022.1004259","article-title":"Comparative efficacy and safety of Chinese medicine injections combined with capecitabine and oxaliplatin chemotherapies in treatment of colorectal cancer: a bayesian network meta-analysis","volume":"13","author":"Liu","year":"2022","journal-title":"Front. Pharmacol."},{"key":"B71","doi-asserted-by":"publisher","first-page":"1461","DOI":"10.3969\/j.issn.1002-7386.2016.10.005","article-title":"Therapeutic effects and action mechanism of lobaplatin combined with Kushen injection on malignant pleural effusion in patients with advanced lung cancer","volume":"38","author":"Liu","year":"2016","journal-title":"Hebei Med. J."},{"key":"B72","doi-asserted-by":"publisher","first-page":"178","DOI":"10.3969\/j.issn.1007-614x.2011.09.176","article-title":"Clinical study of compound Kushen injection combined with bleomycin in the treatment of malignant pleural effusion","volume":"13","author":"Liu","year":"2011","journal-title":"Chin. Community Doct"},{"key":"B73","doi-asserted-by":"publisher","first-page":"70","DOI":"10.3389\/fphar.2016.00070","article-title":"The therapeutic efficacy and safety of compound kushen injection combined with transarterial chemoembolization in unresectable hepatocellular carcinoma: an update systematic review and meta-analysis","volume":"7","author":"Ma","year":"2016","journal-title":"Front. Pharmacol."},{"key":"B74","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1002\/1097-0142(19810101)47:1<207::aid-cncr2820470134>3.0.co;2-6","article-title":"Reporting results of cancer treatment","volume":"47","author":"Miller","year":"1981","journal-title":"Cancer"},{"key":"B75","doi-asserted-by":"publisher","first-page":"70","DOI":"10.3969\/j.issn.1672-951X.2001.02.016","article-title":"Clinical obversation of treatint 30 cases of cancerous hydrothorax with injection of cisplation and Yanshu","volume":"7","author":"Ning","year":"2001","journal-title":"Guid. J. TCMP"},{"key":"B76","doi-asserted-by":"publisher","first-page":"n71","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"Bmj"},{"key":"B77","doi-asserted-by":"publisher","first-page":"1903","DOI":"10.1002\/1097-0142(197611)38:5<1903::aid-cncr2820380506>3.0.co;2-a","article-title":"Intracavitary bleomycin in the management of malignant effusions","volume":"38","author":"Paladine","year":"1976","journal-title":"Cancer"},{"key":"B78","doi-asserted-by":"publisher","first-page":"139","DOI":"10.3969\/j.issn.1007-4406.2007.03.002","article-title":"Clinical observation intracavity Kushen injection combined with cisplatin for the treatment of malignant pleural efusion","volume":"16","author":"Pan","year":"2007","journal-title":"Chin. J. Clin. Pharm."},{"key":"B79","first-page":"595","article-title":"Clinical effect of compound sophora flavescens injection in palliative treatment of advanced lung cancer patients with malignant pleural effusion","volume":"27","author":"Peng","year":"2020","journal-title":"Health Everyone"},{"key":"B80","first-page":"257","article-title":"Analysis of the therapeutic effect of compound sophora flavescens injection and cisplatin thoracic perfusion therapy in patients with malignant pleural effusion","author":"Qin","year":"2016","journal-title":"Med. Health"},{"key":"B81","doi-asserted-by":"publisher","first-page":"2311","DOI":"10.3969\/j.issn.1008-8849.2012.21.014","article-title":"Clinical observation of Kangai injection combined with cisplatin in the treatment of malignant pleural effusion","volume":"21","author":"Qu","year":"2012","journal-title":"Mod. J. ITCWM"},{"key":"B82","doi-asserted-by":"publisher","first-page":"739","DOI":"10.14009\/j.issn.1672-2124.2011.08.015","article-title":"Efficacy of Compound Kushen Injection combined with cisplatin for malignant pleural effusion","volume":"11","author":"Ran","year":"2011","journal-title":"Eval. Anal. Drug-Use Hosp. China"},{"key":"B83","doi-asserted-by":"publisher","first-page":"857","DOI":"10.13517\/j.cnki.ccm.2017.08.032","article-title":"Clinical efficacy and safety of compound Kushen injection combined with cisplatin in the treatment of malignant pleural effusion caused by lung cancer","volume":"26","author":"Shi","year":"2017","journal-title":"Chi J. Conval. Med."},{"key":"B84","doi-asserted-by":"publisher","first-page":"30","DOI":"10.13913\/j.cnki.41-1110\/r.2015.03.020","article-title":"Compound Kushen injection combined with cisplatin pleural perfusion in the treatment of 59 cases of malignant pleural effusion","volume":"30","author":"Song","year":"2015","journal-title":"Forum TCM"},{"key":"B85","doi-asserted-by":"publisher","first-page":"l4898","DOI":"10.1136\/bmj.l4898","article-title":"RoB 2: a revised tool for assessing risk of bias in randomised trials","volume":"366","author":"Sterne","year":"2019","journal-title":"Bmj"},{"key":"B86","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1080\/13880209.2021.1915340","article-title":"Efficacy and safety of Chinese patent medicine (Kang-ai injection) as an adjuvant in the treatment of patients with hepatocellular carcinoma: a meta-analysis","volume":"59","author":"Sun","year":"2021","journal-title":"Pharm. Biol."},{"key":"B87","doi-asserted-by":"publisher","first-page":"143","DOI":"10.3969\/j.issn.0411-8421.2012.02.048","article-title":"Bleomycin combined with compound Kushen injection in the treatment of 25 cases of malignant pleural effusion","volume":"47","author":"Sun","year":"2012","journal-title":"Zhejiang J. TCM"},{"key":"B88","doi-asserted-by":"publisher","first-page":"19","DOI":"10.3969\/j.issn.1007-8517.2014.19.zgmzmjyyzz201419013","article-title":"Meta-analysis of Kang\u2019ai injection combined with cisplatin in the treatment of malignant pleural effusion","volume":"23","author":"Tang","year":"2014","journal-title":"Chin. J. Ethnomed Ethnopharm"},{"key":"B89","doi-asserted-by":"publisher","first-page":"1668","DOI":"10.13192\/j.issn.1000-1719.2018.08.036","article-title":"Cinical objective on sixty cases of compound Kushen Injection combined with cisplatin in treatment of lung cancer pleural effusion","volume":"45","author":"Tang","year":"2018","journal-title":"Liaoning J. TCM"},{"key":"B90","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1093\/ije\/dyn179","article-title":"Can trial sequential monitoring boundaries reduce spurious inferences from meta-analyses?","volume":"38","author":"Thorlund","year":"2009","journal-title":"Int. J. Epidemiol."},{"volume-title":"User manual for trial sequential analysis (TSA)","year":"2016","author":"Thorlund","key":"B91"},{"key":"B92","doi-asserted-by":"publisher","first-page":"175","DOI":"10.3969\/j.issn.1672-2779.2010.18.133","article-title":"Meta-Analysis of TCM injection in the treatment of malignant pleural effusion","volume":"8","author":"Tian","year":"2010","journal-title":"Chin. Med. MDE China"},{"key":"B93","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1016\/S1053-4296(03)00031-6","article-title":"CTCAE v3.0: development of a comprehensive grading system for the adverse effects of cancer treatment","volume":"13","author":"Trotti","year":"2003","journal-title":"Semin. Radiat. Oncol."},{"key":"B94","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1177\/1534735417734913","article-title":"The effect of transarterial chemoembolization in combination with Kang'ai injection on patients with intermediate stage hepatocellular carcinoma: a prospective study","volume":"17","author":"Wan","year":"2018","journal-title":"Integr. Cancer Ther."},{"key":"B95","doi-asserted-by":"publisher","first-page":"108688","DOI":"10.1016\/j.intimp.2022.108688","article-title":"The intrapleural administration with thymic peptides in malignant pleural effusion: a clustered systematicreview and meta-analysis","volume":"107","author":"Wang","year":"2022","journal-title":"Int. Immunopharmacol."},{"key":"B96","doi-asserted-by":"publisher","first-page":"154847","DOI":"10.1016\/j.phymed.2023.154847","article-title":"The evidence framework of traditional Chinese medicine injection (Aidi injection) in controlling malignant pleural effusion: a clustered systematic review and meta-analysis","volume":"115","author":"Wang","year":"","journal-title":"Phytomedicine"},{"key":"B97","doi-asserted-by":"publisher","first-page":"582447","DOI":"10.3389\/fphar.2021.582447","article-title":"The optimal adjuvant strategy of aidi injection with gemcitabine and cisplatin in advanced non-small cell lung cancer: a meta-analysis of 70 randomized controlled trials","volume":"12","author":"Wang","year":"2021","journal-title":"Front. Pharmacol."},{"key":"B98","first-page":"2","article-title":"Sophora radix astragali injection combined cisplatin intrathoracic injection clinical observation on treatment of lung cancer hydrothorax","volume":"24","author":"Wang","year":"2016","journal-title":"Clin. Res."},{"key":"B99","doi-asserted-by":"publisher","first-page":"67","DOI":"10.3969\/j.issn.2096-3327.2023.10.011","article-title":"Efficacy and safety of compound Kushen injection in the treatment of malignant pleural effusions caused by breast cancer","volume":"20","author":"Wang","year":"","journal-title":"China Licens. Pharm."},{"key":"B100","doi-asserted-by":"publisher","first-page":"1298","DOI":"10.4103\/0973-1482.199538","article-title":"Efficacy of compound Kushen injection plus radiotherapy on nonsmall-cell lungcancer: a systematic review and meta-analysis","volume":"12","author":"Wang","year":"2016","journal-title":"J. Cancer Res. Ther."},{"key":"B101","doi-asserted-by":"publisher","first-page":"148","DOI":"10.4103\/0973-1482.199538","article-title":"Clinical observation of Compound Kushen Injection in the treatment of malignant pleural effusion","volume":"11","author":"Wang","year":"2016","journal-title":"China Pract. Med."},{"key":"B102","doi-asserted-by":"publisher","first-page":"148","DOI":"10.3969\/j.issn.1673-9523.2010.05.144","article-title":"Clinical study of compound Kushen injection combined with cisplatin in the treatment of malignant pleural effusion","volume":"4","author":"Wang","year":"2010","journal-title":"Chin. J. Mod. Drug Appl."},{"key":"B103","doi-asserted-by":"publisher","first-page":"116+121","DOI":"10.19613\/j.cnki.1671-3141.2019.02.075","article-title":"Short term efficacy of pleural cavity drainage and infusion of compound Sophora flavescens injection combined with cisplatin in the treatment of malignant pleural effusion in lung cancer","volume":"19","author":"Wang","year":"2019","journal-title":"World Latest Med. Inf."},{"key":"B104","first-page":"13","article-title":"Effect of closed thoracic drainage with central venous catheters and combining cisplatinum(DDP) with matrine to pure into the thoracic cavity with malignant pleural effusion","volume":"21","author":"Wang","year":"2010","journal-title":"Hainan Med. J."},{"key":"B105","first-page":"26","article-title":"Efficacy of compound Kushen injection combined with cisplatin in the treatment of malignant pleural effusion","volume":"9","author":"Wei","year":"2011","journal-title":"JCM"},{"key":"B106","doi-asserted-by":"publisher","first-page":"352","DOI":"10.3969\/j.issn.1672-4992.2014.02.33","article-title":"A clinical observation of intrathoracic injection of OK-432 combined with compound Kushen injection for patients with malignant pleural effusion","volume":"22","author":"Wei","year":"2014","journal-title":"J. Mod. Oncol."},{"key":"B107","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.jclinepi.2007.03.013","article-title":"Trial sequential analysis may establish when firm evidence is reached in cumulative meta-analysis","volume":"61","author":"Wetterslev","year":"2008","journal-title":"J. Clin. Epidemiol."},{"key":"B108","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1186\/1471-2288-9-86","article-title":"Estimating required information size by quantifying diversity in random-effects model meta-analyses","volume":"9","author":"Wetterslev","year":"2009","journal-title":"BMC Med. Res. Methodol."},{"key":"B109","doi-asserted-by":"publisher","first-page":"85","DOI":"10.13192\/j.issn.1000-1719.2019.01.029","article-title":"Clinical study of compound radix sophorae flavescentis injection combined with cisplatin in treatment of malignant pleural effusion","volume":"46","author":"Wu","year":"2019","journal-title":"Liaoning J. TCM"},{"key":"B110","doi-asserted-by":"publisher","first-page":"2421","DOI":"10.6039\/j.issn.1001-0408.2018.17.27","article-title":"Systematic review on the efficacy and safety of adjuvant therapy of compound kushen injection for pleural effusion in elderly patients with malignant cancer","volume":"29","author":"Wu","year":"2018","journal-title":"China Pharm."},{"key":"B111","doi-asserted-by":"publisher","first-page":"3705","DOI":"10.3969\/j.issn.1002-7386.2014.24.007","article-title":"Therapeutic effect of hydroxycamptothecin combined with Kushen Injection on malignant pleural effusion in elderly patients with lung cancer","volume":"36","author":"Wu","year":"2014","journal-title":"Hebei Med. J."},{"key":"B112","doi-asserted-by":"publisher","first-page":"153260","DOI":"10.1016\/j.phymed.2020.153260","article-title":"Intrathoracic infusion therapy with Lentinan and chemical irritants for malignant pleural effusion: a systematic review and meta-analysis of 65 randomized controlled trials","volume":"76","author":"Xiao","year":"","journal-title":"Phytomedicine"},{"key":"B113","doi-asserted-by":"publisher","first-page":"104637","DOI":"10.1016\/j.phrs.2020.104637","article-title":"Clinical efficacy and safety of aidi injection combination with vinorelbine and cisplatin for advanced non-small-cell lung carcinoma: a systematic review and meta-analysis of 54 randomized controlled trials","volume":"153","author":"Xiao","year":"","journal-title":"Pharmacol. Res."},{"key":"B114","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1016\/j.intimp.2018.06.012","article-title":"Clinical efficacy and safety of CIK plus radiotherapy for lung cancer: a meta-analysis of 16 randomized controlled trials","volume":"61","author":"Xiao","year":"2018","journal-title":"Int. Immunopharmacol."},{"key":"B115","doi-asserted-by":"publisher","first-page":"84","DOI":"10.14164\/j.cnki.cn11-5581\/r.2013.17.204","article-title":"Clinical observation of compound Kushen injection in the treatment of malignant pleural effusion","volume":"7","author":"Xing","year":"2013","journal-title":"Chin. J. Mod. Drug Appl."},{"key":"B116","doi-asserted-by":"publisher","first-page":"44","DOI":"10.3969\/j.issn.1673-5412.2014.01.014","article-title":"Pleural instillation by Yanshu injection and chemotherapy drugs in the treatment of malignant pleural effusion","volume":"27","author":"Xu","year":"","journal-title":"J. Basic Clin. Oncol."},{"key":"B117","first-page":"31","article-title":"Meta-analysis of intrapleural injection of compound kushen injection combined with chemotherapy in treating malignant pleural effusion","volume":"24","author":"Xu","year":"2015","journal-title":"China Pharm."},{"key":"B118","doi-asserted-by":"publisher","first-page":"88","DOI":"10.3969\/j.issn.2095-7629.2014.03.079","article-title":"Efficacy observation of compound Kushen injection and cisplatin for malignant pleural effusion","volume":"12","author":"Xu","year":"","journal-title":"Contemp. Med. Symp."},{"key":"B119","doi-asserted-by":"publisher","first-page":"114","DOI":"10.3969\/j.issn.1008-5971.2008.02.010","article-title":"Intrapleural injection of Kangai zhusheye with cisplatin in malignant pleural efusion","volume":"16","author":"Xu","year":"2008","journal-title":"Pract. J. Card. Cereb. Pneum. Vasc. Dis."},{"key":"B120","doi-asserted-by":"publisher","first-page":"942941","DOI":"10.3389\/fonc.2022.942941","article-title":"Chinese herbal injections versus intrapleural cisplatin for lung cancer patients with malignant pleural effusion: a Bayesian network meta-analysis of randomized controlled trials","volume":"12","author":"Xu","year":"2022","journal-title":"Front. Oncol."},{"key":"B121","doi-asserted-by":"publisher","first-page":"574","DOI":"10.3969\/j.issn.1004-0412.2016.03.025","article-title":"The application of compound sophora injection combined with cisplatin in the treatment of malignant pleural effusion by pleural perfusion","volume":"37","author":"Yan","year":"2016","journal-title":"Jilin Med. J."},{"key":"B122","first-page":"1079","article-title":"The recent efficacy of compound Kushen injection combined with cisplafin chest perfusion for malignant pleurai effussion","volume":"7","author":"Yang","year":"2012","journal-title":"China Med."},{"key":"B123","doi-asserted-by":"publisher","first-page":"3393","DOI":"10.3969\/j.issn.1672-4992.2016.21.013","article-title":"Compound Kushen injection combined with cisplatin for treatment of malignant pleural effusion:A Meta -analysis","volume":"24","author":"Yang","year":"2016","journal-title":"J. Mod. Oncol."},{"key":"B124","doi-asserted-by":"publisher","first-page":"4686","DOI":"10.6039\/j.issn.1001-0408.2017.33.22","article-title":"Network meta-analysis of 5 kinds of TCM injections in the treatment of malignant pleural effusion","volume":"28","author":"Yang","year":"2017","journal-title":"China Pharm."},{"key":"B125","doi-asserted-by":"publisher","first-page":"1891","DOI":"10.3969\/j.issn.1001-0408.2007.24.023","article-title":"Thoracentesis and drainage combined with Yanshu injection for malignant pleural effusion","volume":"18","author":"Yuan","year":"2007","journal-title":"China Pharm."},{"key":"B126","first-page":"1691","article-title":"Systematic review of platinum antitumor drugs combined with Mannatide in the treatment of malignant pleural effusion","volume":"22","author":"Zhang","year":"2011","journal-title":"China Pharm."},{"key":"B127","doi-asserted-by":"publisher","first-page":"601","DOI":"10.14009\/j.issn.1672-2124.2015.05.015","article-title":"Effiacy and safety of compound Kushen injection plus nedaplatin for malignant pleural effusion in patients with lung cancer","volume":"15","author":"Zhang","year":"","journal-title":"Eval. Anal. Drug-Use Hosp. China"},{"key":"B128","first-page":"1218","article-title":"Clinical study of compound Kushen injection combined with cisplatin on malignant pleural effusion","volume":"5","author":"Zhang","year":"2008","journal-title":"World Health Dig."},{"key":"B129","doi-asserted-by":"publisher","first-page":"1427","DOI":"10.3969\/j.issn.1000-1719.2006.11.028","article-title":"Clinical effect of Kangai injection combined with cisplatin on malignant pleural effusion","volume":"33","author":"Zhang","year":"2006","journal-title":"Liaoning J. TCM"},{"key":"B130","first-page":"281","article-title":"Clinical observation of compound sophora flavescens injection in the treatment of cancerous Pleural effusion","volume":"25","author":"Zhang","year":"2011","journal-title":"J. Chin. Pract. Diagn Ther."},{"key":"B131","doi-asserted-by":"publisher","first-page":"780","DOI":"10.13455\/j.cnki.cjcor.2013.07.019","article-title":"Clinical study of compound Kushen injection combined with mitomycin for malignant pleural efusion","volume":"20","author":"Zhang","year":"2013","journal-title":"Chin. J. Clin. Oncol. Rehabil."},{"key":"B132","doi-asserted-by":"publisher","first-page":"166","DOI":"10.3969\/j.issn.1003-6350.2015.02.0059","article-title":"Effect of compound matrine intracavity perfusion on VEGF, MMP levels in hydrothorax in patients of malignant pleural effusion","volume":"26","author":"Zhang","year":"","journal-title":"Hainan Med. J."},{"key":"B133","first-page":"416","article-title":"Clinical observation of pleural perfusion in the treatment of malignant pleural effusion","volume":"35","author":"Zheng","year":"2013","journal-title":"Hebei Med. J."},{"key":"B134","doi-asserted-by":"publisher","first-page":"8","DOI":"10.3969\/j.issn.1672-9463.2015.03.003","article-title":"A clinical observation of intrapleural perfusion of OK-432 combined with compound Kushen injection in treatment of malignant pleural effusion","volume":"17","author":"Zhong","year":"2015","journal-title":"Mod. Med. J. China"},{"key":"B135","first-page":"1402","article-title":"Clinical observation on compound matrine injection plus interleukin-2 in the treatment of malignant pleural effusion induced by lung cancer in elder","volume":"15","author":"Zhou","year":"2010","journal-title":"Chin. J. Clin. Pharm. Ther."},{"key":"B136","first-page":"30","article-title":"Clinical study of perfusion with compound Kushen injection plus cisplatin for malignant pleural fluid","volume":"25","author":"Zhu","year":"2013","journal-title":"Tianjin Pharm."},{"key":"B137","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1038\/s41598-020-80297-y","article-title":"Molecular mechanism of the anti-inflammatory effects of Sophorae Flavescentis Aiton identified by network pharmacology","volume":"11","author":"Zhu","year":"2021","journal-title":"Sci. Rep."},{"key":"B138","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.3969\/j.issn.1002-7386.2013.03.055","article-title":"Matrine injection combined with intrapleural cisplatin in treatment of 24 patients with hematologic malignancies complicated by pleural effusion","volume":"21","author":"Zhuang","year":"2012","journal-title":"Chin. J. New Drugs"}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2025.1519794\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,24]],"date-time":"2025-04-24T05:26:37Z","timestamp":1745472397000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2025.1519794\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,24]]},"references-count":138,"alternative-id":["10.3389\/fphar.2025.1519794"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2025.1519794","relation":{},"ISSN":["1663-9812"],"issn-type":[{"type":"electronic","value":"1663-9812"}],"subject":[],"published":{"date-parts":[[2025,4,24]]},"article-number":"1519794"}}